AU2003238678A1 - Novel crystalline forms of sumatriptan succinate - Google Patents
Novel crystalline forms of sumatriptan succinateInfo
- Publication number
- AU2003238678A1 AU2003238678A1 AU2003238678A AU2003238678A AU2003238678A1 AU 2003238678 A1 AU2003238678 A1 AU 2003238678A1 AU 2003238678 A AU2003238678 A AU 2003238678A AU 2003238678 A AU2003238678 A AU 2003238678A AU 2003238678 A1 AU2003238678 A1 AU 2003238678A1
- Authority
- AU
- Australia
- Prior art keywords
- crystalline forms
- novel crystalline
- sumatriptan succinate
- sumatriptan
- succinate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2003/000180 WO2004099140A1 (en) | 2003-05-08 | 2003-05-08 | Novel crystalline forms of sumatriptan succinate |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003238678A1 true AU2003238678A1 (en) | 2004-11-26 |
Family
ID=33428279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003238678A Abandoned AU2003238678A1 (en) | 2003-05-08 | 2003-05-08 | Novel crystalline forms of sumatriptan succinate |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003238678A1 (en) |
WO (1) | WO2004099140A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009128089A2 (en) * | 2008-02-11 | 2009-10-22 | Matrix Laboratories Limited | Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same |
US9603937B2 (en) * | 2015-03-09 | 2017-03-28 | Theaprin Pharmaceuticals Inc. | Platform drug delivery system utilizing crystal engineering and theanine dissolution |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
ES2033578B1 (en) * | 1991-06-06 | 1995-01-16 | Quimica Sint S A Con El 50 | PROCEDURE FOR OBTAINING 3- (2- (DIMETHYLAMINE) ETHYL) -N-METHYL-1H-INDOL-5-METHANOSULFONAMIDE. |
-
2003
- 2003-05-08 AU AU2003238678A patent/AU2003238678A1/en not_active Abandoned
- 2003-05-08 WO PCT/IN2003/000180 patent/WO2004099140A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004099140A1 (en) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003202924A1 (en) | Variation of neural-stimulation parameters | |
AU2003218758A1 (en) | Derivatives of 1-phenyl-3-phenylpyrazole as herbicides | |
AU2003266346A1 (en) | Stabillization of organic materials | |
AU2003279366A1 (en) | Novel compounds | |
AU2003230192A1 (en) | Novel crystalline forms of aripiprazole | |
AU2003255551A1 (en) | Characterisation of paper | |
AU2003303648A1 (en) | Novel 5-hydroxyindole-3-carboxylate derivatives | |
AU2003245027A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
AU2003222439A1 (en) | Novel crystalline forms of tegaserod maleate | |
AU2003250858A1 (en) | Use of organic compounds | |
AU2003280578A1 (en) | Heterocyclic compounds | |
AU2003282162A1 (en) | Novel adhesives comprising diacetals | |
AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
AU2003229459A1 (en) | Methods of using thiazolidinedithione derivatives | |
AU2003238678A1 (en) | Novel crystalline forms of sumatriptan succinate | |
AU2003228950A1 (en) | Oocyte recording chamber | |
AU2003298725A1 (en) | Preparation of metallotexaphyrins | |
AU2003257541A1 (en) | Novel crystals | |
AU2003217437A1 (en) | Novel crystalline forms of lamotrigine | |
AU2003278422A1 (en) | Amorphous form of losartan potassium | |
AU2003251259A1 (en) | Novel compounds | |
AU2003238034A1 (en) | Novel use of imidazotriazinones | |
AU2003238669A1 (en) | Novel crystalline forms of parecoxib sodium | |
AU2003238668A1 (en) | Novel crystalline forms of valdecoxib | |
AU2003264861A1 (en) | Novel crystalline forms of celecoxib |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |